Jump to start of content

Complete requirements by 12/31/19 to avoid a change in certification status Expand/Collapse the ABIM alert.

Sign in to your Physician Portal to view any remaining requirements for the year. Not completing these requirements by 12/31/19 could result in a change to your certification status.

Breadcrumb trail:

Cardiovascular Board Adult Congenital Heart Disease Exam Committee

Expand All | Collapse All

Jamil A. Aboulhosn, MD, Chair

Jamil A. Aboulhosn, MD, ChairDr. Aboulhosn, a board certified cardiologist, is Associate Professor of Medicine and Pediatrics in the Division of Cardiology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). He is the Director of the Ahmanson/UCLA Adult Congenital Heart Disease Center. He was awarded the Streisand American Heart Association Chair in Cardiology in 2014.

Previously, Dr. Aboulhosn served as the Director of Clinical Research at the Ahmanson/UCLA Adult Congenital Heart Disease Center and the Director of the Westwood Heart Center Non-Invasive Imaging Laboratory. From 2009 to 2012, he served as the Director of Adult Congenital Heart Disease at the Children's Heart Center Nevada.

Dr. Aboulhosn is the current Chairman of the Global Research Working Group for the International Society for Adult Congenital Heart Disease. He is also the Vice-Chairman of the Adult Congenital Heart Association's Medical Advisory Board. He is a member of the American Board of Internal Medicine Cardiovascular Board Adult Congenital Heart Disease Exam Committee. He is also an active member and fellow of the Society for Cardiac Angiography and Interventions and the American College of Cardiology. Dr. Aboulhosn is also a founding member and former President and Secretary of the Association for Adult Research in Congenital Cardiology. He serves on the editorial board of the American Journal of Cardiology and is a guest editor for Circulation.

Dr. Aboulhosn received his bachelor's degree in biomedical sciences from the University of California, Riverside and his medical degree from UCLA. He completed his house-staff and adult cardiology training at Harbor-UCLA Medical Center followed by a fellowship in adult congenital heart disease at UCLA.

As of May 2019, Dr. Aboulhosn reported the following external relationships:

Funding for clinical trial expenses and staff, paid to UCLA School of Medicine, from the following companies:

  • Abbott, funding a study to assess the safety and effectiveness of a device used in patients with patent foramen ovale and who have had a stroke of unknown cause.
  • Actelion Pharmaceuticals, funding a study of macitentan in Eisenmenger syndrome and a study assessing the effect of macitentan compared to placebo on exercise capacity through cardiopulmonary exercise testing.
  • Edwards Lifesciences, funding a study of the safety and effectiveness of pulmonic transcatheter heart valve implantation in patients requiring treatment for moderate or severe pulmonary regurgitation and a study to assess the safety and effectiveness of an investigational device when used in combination with a transcatheter heart valve for the treatment of significant backflow of blood in a dysfunctional right ventricular outflow tract.

Attendance at investigators' meetings, with compensation for travel expenses from the following company:

  • Actelion Pharmaceuticals, for planning of a clinical trial on macitentan use in Fontan patients.

Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses:

  • Actelion Pharmaceuticals, for service on a panel for a registry and upcoming clinical trial of macitentan in Fontan patients.

Post-marketing clinical research, with funding provided to UCLA School of Medicine, from the following company:

  • St. Jude, post-marketing study of erosions with a septal occluder device.
  • Abbott, post-marketing study to assess the safety and effectiveness of a device used in patients with patent foramen ovale and who have had a stroke of unknown cause.

Dr. Aboulhosn serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Adult Congenital Heart Association, Vice-Chairman of Medical Advisory Board, without compensation.

Craig Broberg, MD, MCR

Craig Broberg, MD, MCRDr. Broberg is an Associate Professor of Cardiovascular Disease and Radiology and Director of the Adult Congenital Heart Program at Oregon Health & Sciences University (OHSU).

He is actively involved in adult congenital heart research including serving as founding member and past president of the Alliance for Adult Research in Congenital Cardiology (AARCC), a multicenter research network. He is an established independent investigator with a prior NHLBI K23 training grant, investigating the role of myocardial fibrosis in heart failure in congenital heart disease, and an R34 feasibility grant on bicuspid valve aortopathy. He has also held Grants-in-Aid from the American Heart Association, studying single ventricle/Fontan patients and systemic right ventricles. Dr. Broberg has given numerous research and educational talks internationally, including organizing the International Symposium on Congenital Heart Disease in the Adult triannually. He serves on the Medical Advisory Board for the Adult Congenital Heart Association.

Additionally, Dr. Broberg is a member of the American Board of Internal Medicine Cardiovascular Board Adult Congenital Heart Disease Exam Committee. He is board certified in Cardiovascular Disease and Adult Congenital Heart Disease.

His academic training includes a bachelor’s degree from Brigham Young University and medical degree from the University of California, San Francisco, followed by residency training at the University of Washington and cardiovascular fellowship at OHSU. Dr. Broberg spent two years at the Royal Brompton Hospital in London doing an advanced fellowship in adult congenital heart disease and cardiovascular magnetic resonance. He also completed a master’s degree in clinical research (MCR).

As of May 2019, Dr. Broberg reported the following external relationships:

Dr. Broberg serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Adult Congenital Heart Association, Medical Advisory Board, Member, without compensation.

Stephen C. Cook, MD

Dr. Cook is the Director of the Adult Congenital Heart Program at Spectrum Health Helen DeVos Children's Hospital, and Clinical Associate Professor in the department of Pediatrics and Human Development at Michigan State University College of Human Medicine. He is board-certified in pediatric cardiology, adult cardiovascular medicine, and adult congenital heart disease (ACHD).

Dr. Cook earned his medical degree from Boston University School of Medicine, Boston, MA. He completed a combined internal medicine and pediatric residency at Albert Einstein Medical Center, Philadelphia, PA followed by combined pediatric and adult cardiology fellowship at Nationwide Children's Hospital and The Ohio State University, Columbus, OH. He specializes in cardiac magnetic resonance for the assessment and management of adults with complex CHD. Dr. Cook was a founding member of the Alliance for Adult Research in Congenital Cardiology and previously served as the Co-Chair of the Adult Congenital Heart Association Research Committee.

His clinical research interests include assessment of quality metrics and patient-reported outcomes in ACHD, and multi-center studies to assess residents and fellows knowledge of ACHD medicine with over 65 publications in peer-reviewed medical journals. Dr. Cook serves on the American College of Cardiology Writing Group for the development of Appropriate Use Criteria for Congenital Heart Disease for Multi-Modality Imaging.

As of August 2018, Dr. Cook reported no external relationships.

Curt J. Daniels, MD

Curt J. Daniels, MDDr. Daniels is the Dottie Dohan Shepard Endowed Chair and Professor of Clinical Internal Medicine and Pediatrics in the Division of Cardiology at The Ohio State University and the Division of Pediatric Cardiology at Nationwide Children's Hospital. He is the Director of the Columbus Ohio Adult Congenital Heart Disease and Pulmonary Hypertension Programs (COACH) at both facilities. Dr. Daniels is board certified in both pediatric cardiology and internal medicine cardiology.

Dr. Daniels serves on the Adult Congenital/Pediatric Cardiology Council and is the Chair of the ACHD Working Group of the American College of Cardiology. In addition, Dr. Daniels serves as Chair of the Adult Congenital Heart Association Medical Advisory Board, and is Chair of the ACHA ACHD Program Accreditation Committee. Dr. Daniels is committed to education and has trained fellows in ACHD since 2001. The fellowship became formalized as a 24-month training program under the Schooler ACHD Fellowship in 2010. He has also worked to develop a subspecialty board certification in ACHD and currently serves as the Chair of the ABIM ACHD Subspecialty Board Certification Committee.

For the past eight years Dr. Daniels has led a bi-monthly regional patient education lecture series for ACHD patients and has led the effort to provide a personalized electronic medical record for all patients followed in the ACHD program. Dr. Daniels has designed, implemented and successfully completed multiple ACHD research studies and presented his research nationally and internationally. In collaboration with colleagues from The Ohio State University and Nationwide Children's Heart Center, he has mentored fellows training thru the NIH T32 Training Grant entitled “Training in Congenital Heart Disease.” In 2011 Dr. Daniels was elected President of the International Society for ACHD and plans to develop Global Health Initiatives for ACHD. In 2014, he was selected as Co-Chair of the ACC/AHA ACHD Care Guidelines.

Dr. Daniels is a graduate of the Ohio State University College of Medicine. He completed his residency and fellowship at The Ohio State University Medical Center and Nationwide Children's Hospital.

As of April 2019, Dr. Daniels reported the following external relationships:

Funding for clinical trial expenses and staff, paid to The Ohio State University, from the following companies:

  • Actelion Pharmaceuticals Ltd., providing funding for a clinical trial to assess the efficacy, safety and tolerability of macitentan in subjects with Eisenmenger syndrome.

Dr. Daniels reported continuing medical education supported by the following, with compensation for travel expenses and honoraria:

  • Medtronic, continuing medical education regarding transcatheter pulmonary valve treatment and congenital heart disease.

Dr. Daniels serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Adult Congenital Heart Association, Chair of Medical Advisory Board, Board of Directors, Chair of Adult Congenital Heart Disease workgroup and Adult Congential and Pediatric Cardiology Council, without compensation.

Anne M. Dubin, MD

Anne M. Dubin, MDDr. Dubin is the Director of the Pediatric Arrhythmia Service at Lucile Packard Children's Hospital at Stanford, and is a Professor of Pediatrics at Stanford University. She is board certified in both Pediatric Cardiology and Adult Congenital Heart Disease. Dr. Dubin has been a member of the pediatric cardiology division at Stanford since 1995.

She has served on the National Heart, Lung, and Blood Institute (NHLBI) Clinical and Integrative Cardiovascular Science Study Section as well as the NHLBI Electromagnetic Devices Study Section. Dr. Dubin is a member of the Scientific and Clinical Documents Committee for Heart Rhythm Society and serves on the American Board of Internal Medicine Cardiovascular Board Adult Congenital Heart Disease Exam Committee.

She received a degree in biochemistry from Mount Holyoke College and her medical degree from University of Rochester School of Medicine and Dentistry. She completed internship and residency at Babies Hospital, Columbia-Presbyterian Medical Center (now Morgan Stanley Children's Hospital), and her pediatric cardiology fellowship at Children's Hospital of Philadelphia and Yale Medical Center. Dr. Dubin also completed an adult electrophysiology fellowship at Yale Medical Center.

As of April 2019, Dr. Dubin reported the following external relationships:

Work funded by educational grants from industry for fellowship support, paid to Stanford University, from the following companies:

  • Abbot
  • Medtronic

Work as an author or editor for following companies, with compensation as listed:

  • UpToDate, receiving compensation for authorship of two articles on pediatric electrophysiology.

Yuli Y. Kim, MD

Yuli Y. Kim, MDDr. Kim completed her undergraduate degree at Georgetown University and medical degree from the University of Virginia. She was an Osler resident at the Johns Hopkins Hospital in Internal Medicine and went on to the Cleveland Clinic for Cardiovascular Medicine fellowship training. She completed a two-year fellowship in Adult Congenital Heart Disease at Boston Children's Hospital and the Brigham and Women's Hospital. She joined Penn Medicine and CHOP as the medical director of the ACHD program in 2010.

Dr. Kim serves as the medical director of the Philadelphia Adult Congenital Heart Center, a joint program between the Children's Hospital of Philadelphia (CHOP) and Penn Medicine as well as the fellowship director for the ACHD fellowship program at the Hospital of the University of Pennsylvania. She is an Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania and board certified in Adult Congenital Heart Disease.

As of August 2019, Dr. Kim reported the following external relationships:

Dr. Kim serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Adult Congenital Heart Association, Medical Advisory Board Member and Co-Chair for Patient Family Committee, without compensation.

Arwa Saidi, MB, BCh, MEd

Arwa Saidi, MB, BCh, MEdDr. Saidi is an adult congenital cardiologist and is Director of the adult congenital heart disease program at the University of Florida in Gainesville, Florida. She is board certified in Pediatric Cardiology, Internal Medicine and Adult Congenital Heart Disease.

Dr. Saidi joined the faculty at the University of Florida in 2003. In 2015, Dr. Saidi served as Director of the American College of Cardiology (ACC) Adult Congenital Heart Disease (ACHD) Self-Assessment Product and has previously served as topic coordinator for the congenital cardiology sessions of the ACC 12. She is a Writing Committee Member of the ACC/American Heart Association Guidelines for the Management of Adults with Congenital Heart Disease (2014 to 2015) and the Pediatric Cardiology Training Guidelines as the American Academy of Pediatrics' representative for ACHD section (2014 to 2015). Dr. Saidi is a course developer and instructor for the Health Care Transition Course at the University of Florida College of Education (2010 to present).

Dr. Saidi is a member of the American Board of Internal Medicine Cardiovascular Board Adult Congenital Heart Disease Exam Committee. She has been a member of the Adult Congenital Heart Association Medical Advisory Board and currently serves on the Board of Directors. She has received the University of Florida Exemplary Teacher Award (2011, 2015) and Outstanding Achievement for Medical Student Education (2009).

Dr. Saidi received her medical degree from the Royal College of Surgeons in Dublin, Ireland, and completed her internal medicine/pediatrics and pediatric cardiology fellowship training at Baylor College of Medicine, Houston, Texas. She completed her master of education degree at the University of Florida College of Education in 2012.

As of February 2019, Dr. Saidi reported the following external relationships:

Dr. Saidi serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Adult Congenital Heart Association, Medical Advisory Board and Board of Directors, receiving reimbursement for travel expenses.

Karen K. Stout, MD

Karen K. Stout, MDDr. Stout is a board certified cardiologist and is Director of the Adult Congenital Heart Disease Program and Director of the Adult Congenital Heart Disease (ACHD) Fellowship at the University of Washington Medical Center and Seattle Children's Hospital. She is a Professor of Cardiology in Medicine and Pediatrics at the University of Washington. Her academic interests are adult congenital heart disease, pregnancy and heart disease and echocardiography.

Dr. Stout is a member of the American Board of Internal Medicine (ABIM) Cardiovascular Board Adult Congenital Heart Disease Exam Committee and the ABIM Cardiovascular Board. She is Chair of the 2015 American College of Cardiology (ACC)/American Heart Association (AHA) Care of Adults with Congenital Heart Disease Guidelines Writing Committee and has chaired or been a member of several AHA scientific statements regarding congenital heart disease. She is a member of the ACC Adult Congenital and Pediatric Cardiology Committee and is Chair of the AHA ACHD Committee.

Dr. Stout earned her medical degree from the University of Arizona. She completed internal medicine residency and chief residency at Oregon Health and Sciences University and Cardiology fellowship at the University of Washington. She completed a congenital heart disease fellowship at Seattle Children's Hospital.

As of April 2019, Dr. Stout reported the following external relationships:

Work as an author or editor for following companies, with compensation as listed:

  • UpToDate, receiving compensation for authorship.

Dr. Stout serves in significant roles with the following organizations, receiving compensation as listed:

  • American College of Cardiology, Member of Adult Congenital and Pediatric Cardiology Council, without compensation.
  • American Congenital Heart Association, Medical Advisory Board, without compensation.
  • American Heart Association, Puget Sound Chapter Board of Directors, without compensation.